Atlas Trials

A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA

Clinical trial NCT00006430 · UNKNOWN

Trial details

NCT number
NCT00006430
Sponsor
National Center for Research Resources (NCRR)
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.